Scientists find potential new therapy for hard-to-treat pediatric asthma patients – Fox News


Fox News

Scientists find potential new therapy for hard-to-treat pediatric asthma patients
Fox News
Between 40 and 70 percent of childhood asthma patients don't respond well to common treatment, but because doctors believe a variety of factors— from the environment to genetics— affect the condition, identifying those who are resistant before an
Genetic variance explains poor response to common asthma medicationsMedical Xpress
Public Release: 21-Apr-2015 Genetic variance explains poor response to EurekAlert (press release)
Genetic Variance Explains Poor Response to Asthma MedicationsDrug Discovery & Development
Allergic Living
all 10 news articles »

View full post on asthma – Google News

Experimental drug halves attacks in hard-to-treat asthma – Fox News


Telegraph.co.uk

Experimental drug halves attacks in hard-to-treat asthma
Fox News
The injectable antibody treatment mepolizumab is designed to help a small group of people with asthma in which white blood cells called eosinophils cause inflammation of lung airways. It reduces the number of eosinophils by inhibiting an immune system
GSK drug halves attacks in hard-to-treat asthmaReuters
GSK runs to Ph3 with upbeat data on drug for severe asthmaFierceBiotech
Experimental Drug May Cut Severe Asthma Attacks: StudyiVillage Entertainment

all 20 news articles »

View full post on asthma – Google News

GSK drug halves attacks in hard-to-treat asthma – Reuters

GSK drug halves attacks in hard-to-treat asthma
Reuters
LONDON (Reuters) – An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success
GlaxoSmithKline Sees Promise in New Drug for Severe AsthmaFox Business

all 3 news articles »

View full post on asthma – Google News